Cellectis SA · Romainville France
Company Description
View Cellectis SA Locations On A US Map
This link will open in a new window
This link will open in a new window Cellectis has found a cure for bad genes. The company develops technologies involving the research and development of rational genome engineering (making changes in the genetics of a cell or organism). The company's research is primarily based on the Meganucleasus, a natural classification of DNA that isolates unique breaks at key locations within living cells. Its patented Meganuclease Recombination Systems technology helps to initiate the rational genome engineering process, which in turn can help treat diseases and augment genetic codes. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Cellectis SA Financials
| Company Type | Private Single Location |
| Fiscal Year-End | December |
| Annual Sales (mil.) | $9.5 |
| Employees | 43 |
Cellectis SA Executives
9 executives listed for Cellectis SA's Romainville, location.
| Title | Name & Bio | Contact |
| Chairman | Christian Policard | Network |
| CEO and Director | André Choulika | Network |
| EVP Corporate Development and Director | David Sourdive | Network |
Competition
Competitive Landscape for Cellectis SA
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Cellectis SA Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!